JPMorgan upgrades HDFC Bank stock rating on valuation appeal By Investing.com

JPMorgan upgraded HDFC Bank to Overweight and cut its price target to INR1,010 from INR1,090, while revising FY26 and FY28 EPS by -0.2% and -1.7% (JPM estimates remain 2-3% below Bloomberg). The stock is down 33% YTD, trading at $24.35 (near a $24.30 52-week low) and at a 1.5x FY28 P/B (a 16-year low) and ~17% discount to ICICI on 12-month forward P/B. Q3 2025 EPS met at $0.4004 but revenue missed at $5.05B vs $5.10B expected; market reaction was neutral. JPM cited expected recovery in system credit growth and ROA improvement as reasons for the upgrade but noted NIM pressure and a lower subsidiary valuation (Rs94 vs Rs129) as drivers of the lower PT; technical indicators (RSI) and InvestingPro fair value analysis point to potential undervaluation.

Analysis

Valuation-driven repositioning in a large private bank creates asymmetric outcomes across the Indian banking complex: incumbents with deep liability franchises can convert a deposit-cost advantage into faster-than-expected ROA recovery, forcing higher-cost lenders and NBFCs to chase funding via term issuance or higher retail pricing. That dynamic compresses margins for smaller banks and non-bank lenders over the next 6–18 months as competition for granular deposits intensifies, while advantaged banks can harvest spread as expensive wholesale stock winds down.

Market reaction has priced forward a slow recovery in system credit and placed disproportionate weight on short-term revenue noise, leaving optionality unreflected — specifically subsidiary valuation uplifts, share buybacks, or targeted capital returns that can re-rate a parent faster than core NIM recovery. Major reversal triggers are clear: an abrupt macro slowdown or regulatory curbs on dividend/subsidiary transfers would re-open downside within weeks, whereas a clean pick-up in retail loan volumes and stable deposit costs would deliver mean reversion over 3–12 months.

For risk allocation, prefer directional exposure that isolates re-rating from macro beta. Use pair strategies to capture relative valuation convergence and employ calendar/vertical option structures to limit downside against idiosyncratic event risk. Monitor flows (FII/FPIs), local liquidity (RBI operations), and 3–6 month deposit competition data as primary indicators to add or trim positions.

Key Decisions for Investors

• Pair trade (medium, 3–12 months): Long HDB equity (or buy-the-dip at ~5–10% below current levels) and short IBN equity sized 0.6–0.8x to neutralize macro beta; target asymmetric upside of 30–60% if HDB re-rates while limiting pair drawdown to ~15% via a stop-loss on relative performance.
• Options collar (defensive, 3–9 months): Buy HDB Jan‑2027 1x ITM call spread (buy cheaper long-dated call, sell nearer-dated call to finance) and sell a small number of OTM puts to reduce cost; objective: capture >2:1 upside if re-rating occurs, max loss limited to premium + assigned shares if put is exercised.
• Volatility arbitrage (tactical, 1–3 months): Sell implied volatility on HDB earnings/event window only after a muted price move and buy a protective OTM put; aim to harvest IV crush while capping tail risk to ~12–15% of position notional.
• Risk cut: If system credit growth prints negative or regulator restricts subsidiary transfers, cut HDB exposure to zero within days and redeploy into high-quality CRR/LCR benefiting banks or short cyclical NBFCs (target short IBN sized to hedge sector exposure).